← CROSS COUNTRY HEALTHCARE INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $8.0m | $37.5m | ($17.0m) | ($57.7m) | ($13.0m) | $132.0m | $188.5m | $72.6m | ($14.6m) | ($94.9m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | $8.0m | $37.5m | ($17.0m) | ($57.7m) | — | — | — | — | — | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $8.7m | $38.8m | ($15.7m) | ($55.9m) | ($12.1m) | $132.0m | $188.5m | — | — | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $764k | $1.3m | $1.2m | $1.8m | $820k | $0 | $0 | — | — | — | |
| Depreciation, Depletion and Amortization | $9.2m | $10.2m | $11.8m | $14.1m | $12.7m | $9.9m | $12.6m | $18.3m | $18.2m | $16.8m | |
| Amortization of Debt Issuance Costs | $1.7m | $651k | $448k | $461k | — | — | — | — | — | — | |
| Amortization of Intangible Assets | $5.0m | — | — | — | — | — | — | — | — | — | |
| Depreciation | $4.2m | $10.2m | $11.8m | $14.1m | $12.7m | $9.9m | $12.6m | $18.3m | $18.2m | $16.8m | |
| Deferred Income Tax Expense (Benefit) | ($5.3m) | ($33.8m) | ($3.4m) | $31.2m | ($932k) | ($9.9m) | $5.1m | $1.3m | ($1.9m) | $10.1m | |
| Share-based Payment Arrangement, Noncash Expense | $3.4m | $4.1m | $3.6m | $3.4m | $5.4m | $6.9m | $7.4m | $6.6m | $6.0m | $7.1m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $917k | $1.8m | — | — | — | $2.2m | $5.3m | $4.9m | $3.0m | $1.8m | |
| Share-based Payment Arrangement, Expense | $3.4m | $4.1m | $3.6m | $3.4m | $5.4m | $6.9m | $7.4m | $6.6m | $6.0m | $7.1m | |
| Goodwill and Intangible Asset Impairment | — | — | — | — | $10.7m | — | — | — | — | — | |
| Goodwill, Impairment Loss | — | — | — | — | $10.1m | — | — | — | $370k | $71.3m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | — | $1.9m | $0 | $1.8m | — | |
| Operating Lease, Impairment Loss | — | — | — | — | $4.5m | $1.7m | $2.8m | $0 | $0 | — | |
| Gain (Loss) on Disposition of Business | $0 | $0 | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Extinguishment of Debt | ($1.6m) | ($5.0m) | ($79k) | ($2.0m) | $0 | $0 | ($3.7m) | ($1.7m) | $0 | $0 | |
| Income Tax Expense (Benefit) | ($4.2m) | ($34.5m) | ($2.5m) | $31.7m | ($188k) | $1.2m | $67.9m | $30.3m | ($1.8m) | $11.3m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $2.2m | $2.2m | |
| Other Nonoperating Income (Expense) | $230k | $155k | $418k | $68k | ($280k) | $770k | $1.3m | ($2k) | $605k | ($9k) | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $30.8m | ($9.7m) | ($2.8m) | $6.6m | $4.7m | $318.4m | $153.2m | ($251.4m) | ($128.3m) | ($56.7m) | |
| Goodwill | $79.6m | $117.6m | $101.1m | $101.1m | $90.9m | $119.5m | $163.3m | $135.4m | $135.1m | $63.8m | |
| Investment Income, Interest | — | — | — | — | — | — | — | — | $2.0m | $3.1m | |
| Derivative, Gain (Loss) on Derivative, Net | $5.8m | $1.6m | $0 | ($1.3m) | $0 | $0 | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $30.1m | $45.5m | $21.0m | $5.5m | $27.2m | ($85.6m) | $134.1m | $248.5m | $120.1m | $48.3m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $6.5m | $5.1m | $4.6m | $2.9m | $4.6m | $7.2m | $8.8m | $14.0m | $8.7m | $8.2m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $1.9m | $86.0m | $1.9m | $0 | $0 | $26.9m | $35.2m | $0 | $0 | — | |
| Net Cash Provided by (Used in) Investing Activities | ($9.8m) | ($91.4m) | ($6.7m) | ($2.9m) | ($4.6m) | ($34.0m) | ($43.9m) | ($13.8m) | ($8.7m) | ($8.2m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | — | $62.0m | $0 | $0 | — | — | — | — | — | — | |
| Repayments of Long-term Debt | $500k | $1.5m | $16.1m | $83.9m | — | — | — | — | — | — | |
| Payments for Repurchase of Common Stock | — | — | $5.0m | $0 | $0 | — | $35.3m | $57.7m | $37.3m | $6.8m | |
| Proceeds from (Payments for) Other Financing Activities | ($152k) | ($13k) | ($2.3m) | ($1.1m) | ($784k) | ($45k) | ($1.0m) | ($508k) | $0 | $0 | |
| Net Cash Provided by (Used in) Financing Activities | ($2.2m) | $50.8m | ($23.8m) | ($17.6m) | ($22.0m) | $119.1m | ($87.6m) | ($221.2m) | ($46.8m) | ($13.0m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $10k | ($11k) | $6k | ($9k) | $8k | ($14k) | $21k | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($24k) | $23k | ($70k) | ($15.0m) | $568k | ($564k) | $2.6m | $13.5m | $64.5m | $27.1m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $1.0m | $1.6m | $1.0m | $3.6m | $17.1m | $81.6m | $108.7m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $3.9m | $3.4m | $6.3m | $4.6m | $2.7m | $5.8m | $12.9m | $7.5m | $1.4m | $1.4m | |
| Income Taxes Paid, Net | $1.8m | $697k | $1.0m | $555k | $612k | $3.6m | $82.9m | $22.0m | $2.4m | ($5.7m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.